This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
broker-rating: Archive
Is It Worth Investing in High Tide (HITI) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in High Tide (HITI). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
HITIPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Nu (NU) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Nu (NU) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
NUNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
DraftKings (DKNG) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), DraftKings (DKNG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
DKNGNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think MasterCard (MA) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in MasterCard (MA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
MAPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Lockheed (LMT): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Lockheed (LMT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
LMTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in KLA (KLAC): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in KLA (KLAC). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
KLACNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think CleanSpark (CLSK) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in CleanSpark (CLSK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
CLSKNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in British American Tobacco (BTI) Based on Bullish Wall Street Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in British American Tobacco (BTI). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
BTINegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
VKTXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Cadence (CDNS) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Cadence (CDNS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
CDNSNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About SoundHound AI (SOUN): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in SoundHound AI (SOUN). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
SOUNNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Vital Farms (VITL) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Vital Farms (VITL). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
VITLPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Oscar Health (OSCR): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Oscar Health (OSCR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
OSCRNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Kyndryl Holdings, Inc. (KD) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Kyndryl Holdings, Inc. (KD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
KDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About The Trade Desk (TTD): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for The Trade Desk (TTD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
TTDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Enviri (NVRI) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Enviri (NVRI) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
NVRINegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Ero Copper (ERO) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Ero Copper (ERO) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
EROPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Signet (SIG) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Signet (SIG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
SIGNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Medpace (MEDP) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Medpace (MEDP). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
MEDPNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Booz Allen (BAH): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Booz Allen (BAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BAHPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Interactive Brokers (IBKR) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Interactive Brokers (IBKR). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
IBKRNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Copart (CPRT): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Copart (CPRT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
CPRTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Dynatrace (DT): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Dynatrace (DT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
DTNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See JPMorgan Chase & Co. (JPM) as a Buy: Should You Invest?
by Zacks Equity Research
The average brokerage recommendation (ABR) for JPMorgan Chase & Co. (JPM) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
JPMNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Li Auto (LI) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Li Auto (LI) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
LIPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth